Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Hemispherx BioPharma (HEB)

Add HEB Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator KarinCA, STOCK_MOMO
Search This Board:
Last Post: 10/20/2014 2:07:35 PM - Followers: 248 - Board type: Free - Posts Today: 14


Hemispherx has in excess of 100 patents comprising its core intellectual property estate covering various forms of double stranded (ds) RNA and their fields of therapeutic application, a fully commercialized product (Alferon N) and a GMP certified manufacturing facilities for its novel pharma products in New Brunswick, New Jersey.

One Penn Center
1617 JFK Blvd., 6th Floor
Philadelphia, PA 19103
Phone: (215) 988-0080
Fax: (215) 988-1739            



The Long Wait Of Hemispherx's Ampligen

Ampligen (Hemispherx)

FDA delays Hemispherx drug vote

Philadelphia Business Journal - by John George  February 2009

PHILADELPHIA, Oct. 23, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) noted today that a member of its Scientific Advisory Board, Prof. Luc Montagnier, a winner of the 2008 Nobel Prize in Physiology and Medicine, confirms the importance of adjuvants in a current article in the Wall Street Journal (Oct. 21, 2008, p.A19).

Hemispherx Biopharma (HEB): One Step Closer


Dear patients:
           We were very pleased that our four years of research trials on Ampligen for Chronic Fatigue Syndrome turned out to be successful. The press release below summarizes the results--that Ampligen was more effective than placebo for improving the exercise capacity among people with severe CFS.

Hemispherx Biopharma, Inc. to Discuss New Chronic Fatigue Syndrome Clinical Data and Year-End 2008 Results On March 19, 2009

Japanese Government Accelerates Hemispherx Biopharma's Ampligen(r) Research Programs for Influenza Protection

Interview with Dr. William Carter April 28,2009

Update Interview Hemispherx Biopharma (HEB) April 28, 2009


Slides of Ampligen® Trial Results Used in Presentation at IACFS/ME Conference   March 19, 2009


A decision was originally expected by February 25, 2009, for the Company's submission of its Ampligen(r) NDA, which is designated as an Orphan Drug for the treatment of Chronic Fatigue Syndrome, which has no FDA approved treatments on the market. Ampligen(r) is also authorized for Emergency (compassionate) Cost Recovery Sales Authorization by the FDA and has a "promising" designation by the Agency on Health Research Quality (AHRQ): "Ampligen(r), an investigational drug that is not approved by the FDA, given intravenously to severely debilitated patients, yielded the most promising results." The extended user fee goal date is now May 25th, 2009.

Chronic Fatigue Syndrome Treatment - Will Ampligen Finally Be Approved?
CDC - Chronic Fatigue Syndrome (CFS).
HHS - Chronic Fatigue Syndrome Advisory Committee (CFSAC)

Department of Health and Human Services Center for Disease Control and Prevention Public Service Announcments in regards to Chronic Fatigue Syndrome

(30 second and 60 second radio ad, 30 second television ad, and message from Dr. Gerberding)






  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
HEB News: Companies Developing Health Products and Ebola Strategies and Today’s Bounce Alert is Everlet, Inc. Analyst Reports by Smal... 10/15/2014 11:56:17 AM
HEB News: Proxy Statement (definitive) (def 14a) 10/10/2014 04:16:51 PM
HEB News: Statement of Changes in Beneficial Ownership (4) 09/09/2014 11:39:13 AM
HEB News: Quarterly Report (10-q) 08/08/2014 04:04:24 PM
HEB News: Statement of Changes in Beneficial Ownership (4) 07/11/2014 01:55:13 PM
#14165   Indeed, going to be a nice one to hold STOCK_MOMO 10/20/14 02:07:35 PM
#14164   Nice volume so far.. ^BrandonTrader^ 10/20/14 02:05:18 PM
#14163   $HEB -- ABCD breakout setting up, macd cross ^BrandonTrader^ 10/20/14 02:04:40 PM
#14162   Sell then STOCK_MOMO 10/20/14 01:31:48 PM
#14161   not looking good tho for boosting the stock! glg20 10/20/14 01:24:14 PM
#14160   5.12 million traded so far STOCK_MOMO 10/20/14 01:19:12 PM
#14159   over million shares traded and still hasnt run! glg20 10/20/14 01:08:50 PM
#14158   Shorts covering, with good reason. HEB going to run STOCK_MOMO 10/20/14 12:49:01 PM
#14157   Scaling in here $HEB ^BrandonTrader^ 10/20/14 12:44:29 PM
#14156   Nice news, in for the ride along with beamin1 10/20/14 12:37:03 PM
#14155   Hemispherx Announces Strategic Relationship With Squire Patton Boggs, STOCK_MOMO 10/20/14 12:31:07 PM
#14154   Nice news out! JefferyScott 10/20/14 12:30:30 PM
#14153   Bring that $1.00 STOCK_MOMO 10/20/14 12:27:55 PM
#14152   Hemispherx Biopharma Prevails in Multi-Million Dollar Federal Lawsuit alexander77 10/20/14 08:52:04 AM
#14151   Much worse to come The 8th Enigma 10/19/14 07:40:52 PM
#14149   apparently the story may be a complete hoax JefferyScott 10/19/14 01:49:44 PM
#14148   Higher lows + bullish engulfing candle with volume TheMotivatedTrader 10/19/14 12:12:37 AM
#14147   Thanks for posting that, very interesting read. Eddessa Capital Investments 10/18/14 11:24:37 PM
#14145   Col. Dr. Sergei Bankoul, M.D., Swiss Armed Forces alexander77 10/18/14 04:06:58 PM
#14144   Amoligen/alferon superioity to treat Ebola: alexander77 10/18/14 03:24:27 PM
#14142   And it will. Next week might be our STOCK_MOMO 10/17/14 04:43:59 PM
#14141   given the ebola issues this week, this should glg20 10/17/14 04:42:22 PM
#14139   Hemispherx BioPharma, Inc. (NYSE-MKT: HEB) is an advanced STOCK_MOMO 10/17/14 04:35:45 PM
#14138   Funny when they throw in the towel... what happens xero90 10/17/14 04:30:47 PM
#14137   I think HEB is the best one to STOCK_MOMO 10/17/14 04:25:58 PM
#14136   Nothing to do short term with HEB share glg20 10/17/14 03:57:57 PM
#14135   and what are the chances of that. glg20 10/17/14 03:28:15 PM
#14134   just needs a good PR. JefferyScott 10/17/14 03:24:01 PM
#14133   This thing cant move. its crazy. glg20 10/17/14 03:19:02 PM
#14132   100% Agree. With the accumulation this week, I STOCK_MOMO 10/17/14 02:58:46 PM
#14131   been holding here for a while now, this JefferyScott 10/17/14 02:55:25 PM
#14130   Might be our turn next week. Lots going STOCK_MOMO 10/17/14 02:45:09 PM
#14129   Volume pouring in... This wants to jump up!! $HEB Tomyt777 10/17/14 01:09:48 PM
#14127   This Ebola is scary stuff. Not to be The 8th Enigma 10/17/14 09:56:50 AM
#14126   This stock should be trading much higher. Soon Tomyt777 10/17/14 12:21:05 AM
#14125   Hemispherx Biopharma and United States Army Medical Research STOCK_MOMO 10/16/14 10:58:53 PM
#14124   What's the millitary connection? The news is reporting Tomyt777 10/16/14 10:03:43 PM
#14123   The two platform drugs of Hemispherx, Alferon(R) N STOCK_MOMO 10/16/14 08:59:44 PM
#14122   Very surprised HEB hasn't taken off yet considering STOCK_MOMO 10/16/14 08:50:44 PM
#14121   They need to release some news that they Tomyt777 10/16/14 04:13:32 PM
#14120   Where is this dollar... glg20 10/16/14 03:53:26 PM
#14119   the pull back and base i assumed was glg20 10/16/14 01:41:48 PM
#14118   This is a classic text book set up. Big Chief 10/16/14 12:38:16 PM
#14117   Ebola spreading is an unfortunate catalyst. The volume Big Chief 10/16/14 12:35:45 PM
#14116   whats unfortunate? glg20 10/16/14 11:29:50 AM
#14115   Text book chart with an unfortunate catalyst. My Big Chief 10/16/14 11:18:26 AM
#14114   Hemispherx Biopharma and United States Army Medical Research STOCK_MOMO 10/16/14 12:08:52 AM
#14113   Here_is why Ebola will_be_the story of the decade The 8th Enigma 10/15/14 10:09:29 PM
#14112   another link I think it's new khasil 10/15/14 05:56:01 PM
#14111   The volume the last few days is telling. STOCK_MOMO 10/15/14 05:15:53 PM